Authors


Anthony Nuara, MD, PhD

Latest:

Post-Relapse Treatment of a 50-Year-Old Male Patient with Vitiligo

Continuing the discussion of a 50-year-old male patient with vitiligo, Anthony Nuara, MD, PhD, addresses the intricacies of treating patients who have relapsed or experienced a loss of efficacy following their initial treatment and highlights how to select 2nd line treatments with greater efficacy.


Brent Moody, MD, FACP, FAAD

Latest:

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.



Sherry G. Cohen, FNP-C, APRN-PMH

Latest:

Sunscreen Protection for Children

Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.


Chesahna Kindred, MD, MBA, FAAD

Latest:

Addressing Causes of Female Hair Loss and Exploring Preventative Measures

This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.


Dustin Portela, DO

Latest:

Pointers With Portela: Minimalist Skin Care Routines

In this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.



Aaron S. Farberg, M.D., dermatologist, Baylor Scott & White Health System and Bare Dermatology in Dallas, Texas

Latest:

Impact of Data on Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.


Ethan Sims, MD

Latest:

Addressing the Health Impacts of a Changing Climate

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.


Andy Curry, PhD

Latest:

Unmasking Botulinum Toxin Myths

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.


Gianna Melendez, MS, Spherix Global Insights

Latest:

Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment Options

Explore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.


Jay A. Lieberman, MD, FACAAI

Latest:

Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual Meeting

Program Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.


Meenal Kheterpal, MD

Latest:

Key Takeaways on Advanced BCC Management

Panelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.



Hailey Brickman, PA-C

Latest:

QUIZ: Sauna-Related Rash - Test Your Medical Insight

“Edward” is a 35-year-old Hispanic male presenting with a new rash on the buttocks which has been present for approximately 1 month.


Linda Stein Gold, MD

Latest:

Differentiating Between JAK Inhibitors in Clinical Practice

Panelists discuss how unique characteristics of different JAK inhibitors, including selectivity profiles, administration routes, and clinical efficacy data, inform treatment selection in real-world practice.


Jennifer Conner, MPAS, PA-C

Latest:

Take-Home Pearls on the Management of Plaque Psoriasis

Alexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.


Savanna Vidal

Latest:

The Skin Smart Campus Initiative: Promoting Skin Health and Public Awareness at GW

George Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.



Tom Ferry, MBA

Latest:

How Physicians Can Provide Better Care for Patients with Chronic Conditions

Technology and care navigators are key to managing this growing population


Lily Guo

Latest:

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.


Bob Peelman

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.



Patrick Burnett, MD, PhD

Latest:

Pipeline Updates on the Horizon From Arcutis Biotherapeutics

Patrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.


James Q. Del Rosso, DO

Latest:

Differentiating Between JAK Inhibitors in Clinical Practice

Panelists discuss how unique characteristics of different JAK inhibitors, including selectivity profiles, administration routes, and clinical efficacy data, inform treatment selection in real-world practice.


Theresa A. Bingemann, MD, FACAA

Latest:

Exploring the Diagnostics of Urticaria at ACAAI

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.


Kim Papp, MD, PhD, FRCPC

Latest:

Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque Psoriasis

Papp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.


James Song, MD, FAAD

Latest:

Differentiating Between JAK Inhibitors in Clinical Practice

Panelists discuss how unique characteristics of different JAK inhibitors, including selectivity profiles, administration routes, and clinical efficacy data, inform treatment selection in real-world practice.


Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

Latest:

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.


Iltefat Hamzavi, MD

Latest:

Potential Role of AI in HS Diagnosis

Panelists discuss how the role of AI in Hidradenitis Suppurativa and the potential for complex multi-input factors.

© 2025 MJH Life Sciences

All rights reserved.